| |
| Media
News by Date |
|
|
| February 2007 |
| Lung
drug. Researchers at UCLA say cyclophosphamide, a drug
typically used to treat cancer, may help slow down lung damage
in scleroderma. Dr. Phillip Clements says there is a mild
to modest benefit. It also softens the skin thickening, that
many people have, and improves their function. WIStv.
02/21/07. (Also see: Cyclophosphamide and Pulmonary
(Lung) Involvement) |
| February
is Raynaud's Awareness Month in the UK. This year, the
Raynaud's & Scleroderma Association celebrates its silver
jubilee. They would like to hear from anyone who suffers
from cold hands and feet, and in return they will send out
a free information pack which contains details of a wide
variety of heating aids and garments to help keep the cold
at bay, including silver socks and gloves. icNewcastle.co.uk.
02/13/07. |
| Raynaud's
disease can leave skin cold, numb. The most common form
of the disorder, called primary Raynaud's, has no underlying
cause or associated medical condition. Another form, often
referred to as Raynaud's phenomenon, is brought on by another
illness or condition like scleroderma, lupus, rheumatoid
arthritis, smoking and certain medications, to name a few. The
Daily Advertiser. 01/09/07. |
| It
may not be crippling, but it can be a pain. Change in
temperature affects shift of blood to extremities. People
are said to have Raynaud's disease, also known as primary
Raynaud's, when there is no underlying disease associated
with their condition. Raynaud's phenomenon, or secondary
Raynaud's, occurs when the condition is caused by a connective
tissue disease such as scleroderma or lupus. Delawareonline.
01/30/07. |
| Space-Age
Bandage Device Lets Doctors Monitor Patients With Raynaud's
Disease. A small group of APL researchers, in collaboration
with physicians from the Johns Hopkins Scleroderma Center
in Baltimore, developed and recently completed initial trials
for a miniature device, worn on a patient's finger, to help
physicians characterize Raynaud’s disease and measure
treatment effectiveness. ScienceDaily. 02/02/07. (Also
see: Raynaud's) |
|
| Keep on Surfing! |
| Go to Scleroderma
Media News: January 2007 |
|
Hello, I am